|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD, Fedewa SA, Butterly
LF, Anderson JC, Cercek A, Smith RA and Jemal A: Colorectal cancer
statistics, 2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dekker E, Tanis PJ, Vleugels J, Kasi PM
and Wallace MB: Colorectal cancer. Lancet. 394:1467–1480. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Li P
and Wu M: circRNA: Functions and properties of a novel potential
biomarker for cancer. Mol Cancer. 16:942017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kristensen LS, Andersen MS, Stagsted L,
Ebbesen KK, Hansen TB and Kjems J: The biogenesis, biology and
characterization of circular RNAs. Nat Rev Genet. 20:675–691. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Soslau G: Circular RNA (circRNA) was an
important bridge in the switch from the RNA world to the DNA world.
J Theor Biol. 447:32–40. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ruan H, Xiang Y, Ko J, Li S, Jing Y, Zhu
X, Ye Y, Zhang Z, Mills T, Feng J, et al: Comprehensive
characterization of circular RNAs in ~1000 human cancer cell lines.
Genome Med. 11:552019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lei B, Tian Z, Fan W and Ni B: Circular
RNA: A novel biomarker and therapeutic target for human cancers.
Int J Med Sci. 16:292–301. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen LY, Wang L, Ren YX, Pang Z, Liu Y,
Sun XD, Tu J, Zhi Z, Qin Y, Sun LN and Li JM: The circular RNA
circ-ERBIN promotes growth and metastasis of colorectal cancer by
miR-125a-5p and miR-138-5p/4EBP-1 mediated cap-independent
HIF-1alpha translation. Mol Cancer. 19:1642020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shang A, Gu C, Wang W, Wang X, Sun J, Zeng
B, Chen C, Chang W, Ping Y, Ji P, et al: Exosomal circPACRGL
promotes progression of colorectal cancer via the
miR-142-3p/miR-506-3p- TGF-β1 axis. Mol Cancer. 19:1172020.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li C, He X, Zhang L, Li L and Zhao W: A
pair-wise meta-analysis highlights circular RNAs as potential
biomarkers for colorectal cancer. BMC Cancer. 19:9572019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liang L and Li L: Down-regulation of
circNRIP1 promotes the apoptosis and inhibits the migration and
invasion of gastric cancer cells by miR-182/ROCK1 axis. Onco
Targets Ther. 13:6279–6288. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fang D and Lu G: Expression and role of
nuclear receptor-interacting protein 1 (NRIP1) in stomach
adenocarcinoma. Ann Transl Med. 8:12932020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ni XF, Zhao LH, Li G, Hou M, Su M, Zou CL
and Deng X: MicroRNA-548-3p and microRNA-576-5p enhance the
migration and invasion of esophageal squamous cell carcinoma cells
via NRIP1 down-regulation. Neoplasma. 65:881–887. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liang ZZ, Guo C, Zou MM, Meng P and Zhang
TT: circRNA-miRNA-mRNA regulatory network in human lung cancer: An
update. Cancer Cell Int. 20:1732020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xiong DD, Dang YW, Lin P, Wen DY, He RQ,
Luo DZ, Feng ZB and Chen G: A circRNA-miRNA-mRNA network
identification for exploring underlying pathogenesis and therapy
strategy of hepatocellular carcinoma. J Transl Med. 16:2202018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhong Y, Du Y, Yang X, Mo Y, Fan C, Xiong
F, Ren D, Ye X, Li C, Wang Y, et al: Circular RNAs function as
ceRNAs to regulate and control human cancer progression. Mol
Cancer. 17:792018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ji Q, Zhang C, Sun X and Li Q: Circular
RNAs function as competing endogenous RNAs in multiple types of
cancer. Oncol Lett. 15:23–30. 2018.PubMed/NCBI
|
|
19
|
Li Q, Pan X, Zhu D, Deng Z, Jiang R and
Wang X: Circular RNA MAT2B promotes glycolysis and malignancy of
hepatocellular carcinoma through the miR-338-3p/PKM2 axis under
hypoxic stress. Hepatology. 70:1298–1316. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen X, Chen RX, Wei WS, Li YH, Feng ZH,
Tan L, Chen JW, Yuan GJ, Chen SL and Guo SJ: PRMT5 circular RNA
promotes metastasis of urothelial carcinoma of the bladder through
sponging miR-30c to induce epithelial-mesenchymal transition. Clin
Cancer Res. 24:6319–6330. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu D, Wu Y, Wang X, Hu X, Qin W, Li Y,
Wang Y, Zhang Z, Lu S, Sun T, et al: Identification of functional
circRNA/miRNA/mRNA regulatory network for exploring prospective
therapy strategy of colorectal cancer. J Cell Biochem.
1:297032020.
|
|
22
|
Li X, Ma N, Zhang Y, Wei H, Zhang H, Pang
X, Li X, Wu D, Wang D, Yang Z and Zhang S: Circular RNA circNRIP1
promotes migration and invasion in cervical cancer by sponging
miR-629-3p and regulating the PTP4A1/ERK1/2 pathway. Cell Death
Dis. 11:3992020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
McQuade RM, Stojanovska V, Bornstein JC
and Nurgali K: Colorectal cancer chemotherapy: The evolution of
treatment and new approaches. Curr Med Chem. 24:1537–1557. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Blondy S, David V, Verdier M, Mathonnet M,
Perraud A and Christou N: 5-fluorouracil resistance mechanisms in
colorectal cancer: From classical pathways to promising processes.
Cancer Sci. 111:3142–3154. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang W, Gu J, Wang X, Wang Y, Feng M, Zhou
D, Guo J and Zhou M: Inhibition of circular RNA CDR1as increases
chemosensitivity of 5-FU-resistant BC cells through up-regulating
miR-7. J Cell Mol Med. 23:3166–3177. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ren TJ, Liu C, Hou JF and Shan FX:
circDDX17 reduces 5-fluorouracil resistance and hinders
tumorigenesis in colorectal cancer by regulating miR-31-5p/KANK1
axis. Eur Rev Med Pharmacol Sci. 24:1743–1754. 2020.PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dong Z, Liu Y, Wang Q, Wang H, Ji J, Huang
T, Khanal A, Niu H and Cao Y: The circular RNA-NRIP1 plays
oncogenic roles by targeting microRNA-505 in the renal carcinoma
cell lines. J Cell Biochem. 121:2236–2246. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang X, Wang S, Wang H, Cao J, Huang X,
Chen Z, Xu P, Sun G, Xu J, Lv J and Xu Z: Circular RNA circNRIP1
acts as a microRNA-149-5p sponge to promote gastric cancer
progression via the AKT1/mTOR pathway. Mol Cancer. 18:202019.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ouyang X, Yao L, Liu G, Liu S, Gong L and
Xiao Y: Loss of androgen receptor promotes HCC invasion and
metastasis via activating circ-LNPEP/miR-532-3p/RAB9A signal under
hypoxia. Biochem Biophys Res Commun. 557:26–32. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ye J, Liu J, Tang T, Xin L, Bao X and Yan
Y: LINC00963 affects the development of colorectal cancer via
miR-532-3p/HMGA2 axis. Cancer Cell Int. 21:872021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jin L, Huang S, Guan C and Chang S:
ETS1-activated SNHG10 exerts oncogenic functions in glioma via
targeting miR-532-3p/FBXL19 axis. Cancer Cell Int. 20:5892020.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dai X, Liu J, Guo X, Cheng A, Deng X, Guo
L and Wang Z: Circular RNA circFGD4 suppresses gastric cancer
progression via modulating miR-532-3p/APC/beta-catenin signalling
pathway. Clin Sci (Lond). 134:1821–1839. 2020.PubMed/NCBI
|
|
34
|
Lin J, Qin H, Han Y, Li X, Zhao Y and Zhai
G: circNRIP1 Modulates the miR-515-5p/IL-25 axis to control 5-Fu
and cisplatin resistance in nasopharyngeal carcinoma. Drug Des
Devel Ther. 15:323–330. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu G, Li M, Wu J, Qin C, Tao Y and He H:
Circular RNA circNRIP1 sponges microRNA-138-5p to maintain
hypoxia-induced resistance to 5-fluorouracil through
HIF-1α-dependent glucose metabolism in gastric carcinoma. Cancer
Manag Res. 12:2789–2802. 2020. View Article : Google Scholar : PubMed/NCBI
|
